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Abstract
“Outbreak” is a term referring to a virus or a parasite that is transmitted very aggres-
sively and therefore could potentially cause fatalities, as the recent Ebola and Zika epi-
demics did. Nevertheless, looking back through history, quite a few outbreaks have 
been reported, which turned out so deadly that essentially changed, molded and liter-
ally re-shaped the society as it is today. In the present chapter, differences and similari-
ties between the two most recent outbreaks have been studied, in order to pinpoint and 
design a trace model that will allow us to draw some conclusions for the connection of 
those two epidemics. Due to the high dimensionality of the problem, modern and state 
of the art geo-epidemiological methods have been used in an effort to provide the means 
necessary to establish the abovementioned model. It is only through geo-epidemiologi-
cal analysis that it is possible to analyze concurrently a multitude of variables, such as 
genetic, environmental, behavioral, socioeconomic and a series of related infection risk 
factors.
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1. Introduction
The Flaviviridae is a diverse viral family of more than 100 known viral species, which has 
a worldwide distribution with several different viral members across the continents of our 
planet [1]. The first Flaviviridae virus outbreak was recorded in 1878 with the yellow fever 
virus at the city of Memphis, Tennessee, a hometown of 45,000–50,000 people that suddenly 
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became a ghost town [2]. At the same time, germ theory was still a state of the art concept. 
Researchers had no idea that the cause of yellow fever was a virus 1000 times smaller in size 
the human eye could detect, and they definitely had no idea that arthropod vectors were the 
carriers, and for this case mosquitoes in particular. Yellow fever virus was isolated for the first 
time in 1927, and it was not until 10 years later that an effective vaccine was developed against 
the fatal virus [3]. Due to the fact that Flaviviridae is a highly mutagenic family of viruses, 
in subsequent outbreaks, several new members have been identified and reported to share 
high similarity in structural conservation and molecular characteristics. Overall, the genus 
Flaviviridae comprises four main genera Hepacivirus, Pegivirus, Pestivirus and Flavivirus [4, 5].
The genus Hepacivirus is the smallest and contains the Hepatitis C Virus (HCV), one of the 
most fatal human pathogens in the Flaviviridae family [6, 7]. The genus Pegivirus was recently 
classified and includes virus species that infect mammals [4, 8]. The genus Pestivirus has not 
been classified as a zoonotic disease yet and contains the bovine viral diarrhea virus (BVD) 
and the classical swine fever virus (CFSV) [4, 9]. Nevertheless their impact on livestock is 
strongly connected with the economic and social well-being of many countries. Last but not 
least the genus Flavivirus is the largest one and contains 70 identified human and animal 
viruses [4] including Dengue virus (DENV), West Nile virus (WNV), Japanese encephalitis 
virus (JEV), Tick-borne encephalitis virus (TBEV), Yellow fever virus (YFV) and Zika virus 
(ZIKV) the last of which recently led to the World Health Organization (WHO) in order to 
declare a global public-health emergency.
Among other common characteristics, the Flaviviridae family viruses spread quickly and eas-
ily in a tropical environment and attribute that the researchers are now re-examining the cur-
rent Zika virus outbreak [10, 11]. In fact, this is down to the way viruses pass from one species 
to another. The viruses within this family fall within significant medical concern as variety of 
diseases inflict to both humans and animals. The majority of these viruses spread by arthro-
pod vectors such as ticks and mosquitoes and in many cases they can also be transmitted from 
animals to humans. Flaviviridae family viruses can survive for long periods in their hosts by 
replicating without damaging the host cell. Generally, humans are infected with these viruses 
by direct contact with infected blood. In America, people have been mostly infected with Zika 
virus through the bites of the Aedes aegypti mosquito [12].
The ability of the Flaviviridae family viruses to spread so rapidly is also due to the structure 
of its viral genome [4, 13]. The Flaviviridae are a family of positive, single-stranded enveloped 
RNA viruses. Their genetic material in the form of ssRNA contains all the information needed 
in order to make copies and it also mutates more easily [14]. Mistakes in replication can hap-
pen in both DNA and RNA, but RNA has fewer systems in place to proofread and correct 
mutations that may naturally arise [15]. In fact the RNA viruses do not have these correcting 
mechanisms at all, so the mutations remain and get passed to the next generation [14]. RNA 
replication has an error rate roughly 10,000 times higher than that of DNA, which means that 
Flaviviridae family viruses evolve much quicker.
Flaviviridae family genera present similarities in the organization of its genetic material, the esti-
mate life cycle, replication and morphology of the viral particles [5]. Virions of Flaviviridae fam-
ily viruses are spherical almost 40–60 nm in diameter. Each virion consists of a lipid envelope 
Current Topics in Zika34
which is composed of two or three virus-encoded membrane proteins, a membrane and a small 
capsid. The genetic material is located within the capsid. The genome includes a single-stranded 
positive sense RNA molecule of approximately 9.5–12.5 kb. It contains a long open reading 
frame (ORF) which is found between untranslated regions (UTRs) at 5′ and 3′ ends. All the fam-
ily members lack 3′ terminal polyadenylated tail. The whole genome is translated into a poly-
protein, which is processed post-translationally by host and viral proteases. This polyprotein 
consists of minimum 10 different products, depending on the classification of the virus that can 
be divided based on structural and non-structural (NS) proteins [7].
2. General epidemiology
Despite the fact that the Zika virus epidemic in the Americas and the Caribbean is showing 
signs of a significant slow-down, Zika virus transmission is continued worldwide. To date, 
148 areas worldwide related with Zika virus from which 61 areas worldwide have confirmed 
the transmission of Zika virus disease, 18 areas have evidence of Zika virus circulation and 
69 have the potential for Zika virus future transmission [16, 17]. Moreover five countries have 
reported sexually transmitted Zika cases [18, 19]. There are critical knowledge gaps around 
Zika virus and a lack of historical reports on its vectors, transmission patterns and geographi-
cal distribution. Regardless these challenges, there is a need to better understand the epi-
demiology of Zika virus transmission in a given area, at a given time in order to allow an 
assessment of the possibility of Zika virus infection for a number of populations, and to adapt 
public health recommendations for residents and travelers [17].
The first isolation of Zika virus was detected in 1948 from the mosquito species Aedes 
africanus [20, 21]. Since then, there have been several new cases of Zika virus vectors reported 
to literature. Collectively, the most frequent mosquito vector is the genus Aedes including, 
A. aegypti, Aedes furcifer, Aedes luteocephalus, Aedes vitattus and Aedes apicoargenteus [22–24]. 
The main vector of the Zika virus in South and South-East Asia is considered to be the genus 
A. aegypti of mosquitoes, which also play a major role as the major transmission vector for 
Dengue virus, Yellow fever virus, Chikungunya virus and many other mosquito-borne flavivi-
ruses [25]. Based on reports during the two major outbreaks in the Pacific Islands, new poten-
tial vectors of Zika virus could be Aedes hensilli and Aedes polynesiensis mosquitoes [26, 27]. 
Moreover, recently another member of mosquitoes within the Aedes genus was found to be 
infected, the Aedes albopictu [12, 28]. Zika virus replicates in mosquitoes within 7–10 days and 
afterwards spreads with high levels of transmission through the salivary glands. However, 
the superiority of either vector over others in its capacity to optimally transmit Zika virus is 
yet to be investigated. Despite the Zika virus reservoir is unclear, some researcher believe that 
Zika virus might be maintained in nature by a sylvatic cycle involving non-human primates, 
or in a broad members of Aedes mosquito’s species [23, 24]. Zika virus transmission in urban 
areas takes place by the anthropophilic mosquitoes A. aegypti and A. albopictus, from which 
the A. albopictus is particularly worrisome from the A. aegypti because of its daily feeding and 
their custom to bite several hosts during the development cycle of their eggs which makes 
them very effective as a transmission vectors [21, 29, 30]. Nevertheless, serological studies 
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have established the presence of particular antiviral antibodies in several mammals including 
elephants, felines and rodents, which confirm that other reservoirs may be involved in the 
transmission cycle of the Zika virus [21, 31]. Therefore, there is an urgent need to identify vec-
tors and possible vectors in vulnerable area in order to control Zika virus outbreaks.
3. Genetic and geo-epidemiological analysis of the Zika virus
Zika virus has been around since the first human case was diagnosed in 1952 [20]. It only 
caused sporadic human infections until the first humongous outbreak on the Micronesian 
island of Yap in 2007 [32]. Even then, the symptoms were reported to share many common 
characteristics with a mild flu symptoms including fever, rash, headaches and joint and muscle 
pain. However, during the Zika virus outbreak in Tahiti in 2013 and 2014, a small number of 
people began to show unusual symptoms that resembled another syndrome called “Guillain-
Barré,” a condition that causes the immune system to attack a person’s nerves, resulting in 
muscle weakness, tingling and even paralysis [33]. Furthermore, pregnant women infected 
with Zika virus have also given birth to babies with microcephaly, or smaller than normal 
heads [34]. It is possible that these new symptoms could be a result of the Zika virus evolu-
tion [35]. Zika virus was relatively infrequent and it did not cause a lot of concern, but when 
new cases were identified with greater frequency and people started to see babies born with 
microcephaly and nervous system disorders, the public health importance of this virus had 
to change completely [36].
The sudden appearance and the rapid global spread of the Zika virus have caused confusion 
regarding the meaning of the term “pandemic” [37]. There is also confusion in the recognition 
of pandemics when they occur. Some believe that the explosive contagiousness is sufficient 
to classify a disease as a pandemic. Another opinion claims that the severity of the infection 
and mortality must be considered. A pandemic is an epidemic of infectious disease that has 
spread throughout human population across a large region such as multiple continents or 
even worldwide [38]. The pandemic is not related to the endemic, which is a disease that 
can be controlled as far as transmissibility is concerned. On the other hand, the pandemic is 
characterized as a lethal threat to humans, since mortality rates may overcome these wars and 
accidents. The main feature of the pandemic is that it is communicable.
A look back in history reveals that pandemics are so expansive and deadly that they essen-
tially changed the course of history such as the Black Death or as well known as “Bubonic 
Plague” in 1339–1351, which affects both Europe and Asia [39]. Painful, egg-sized swellings 
on the body signaled the infected had only a week to live [40]. Being close to a sick person was 
enough to get infected. The total number of worldwide deaths is estimated at 75 million peo-
ple and even today the WHO reports 1000–3000 cases of plague every year [41]. Furthermore, 
Cholera boomed during 1817–1823 in Asia, Middle East and Africa. The cholera bacterium 
lurks in contaminated water and infects the small intestine, causing severe diarrhea. About 
40% of victims die within hours, due to dehydration. Cholera has killed at least 10 million 
people. An estimated 2.86 million cholera cases occur annually in endemic countries. Among 
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these cases, there are an estimated 95,000 deaths [42]. Nowadays, HIV/AIDS is still expanded 
worldwide since 1970, despite the fact that it is originated in central Africa [43, 44]. HIV virus 
viral genome was identified in the early 1980s, after an epidemic expand among homosexual 
men in western countries. HIV is transmitted through bodily fluids and blood, and destroys 
the immune system [45]. HIV infected people with zero immune response are easier to die of 
other diseases such as cancer or pneumonia, or from simple infections. Since there is no cure, 
anti-retroviral drugs are granted to the patients to prevent the virus from spreading and kill-
ing more immune cells. HIV and generally AIDS have killed more than half a million North 
Americans [46]. In Southern Africa, it is estimated that 25 million have lost their lives, with 35 
million more still infected, including many children born with the virus [47].
The World Health Organization (WHO) has produced a six-stage (phasing) classification that 
describes the process by which a novel influenza virus moves from the first few infections in 
humans through a pandemic [48]. The stages do not relate to how sick the person gets or how 
many people are infected by the virus. Instead, they relate to where it is located and how it 
is spread from one area to another. Firstly, viruses circulate within animals only. No human 
infection has resulted from the animal virus. Secondly, if an animal virus infects humans, it 
means that this virus has mutated, so there is a basic level of pandemic threat. Thirdly, small 
groups of people in a region are infected by the virus. It is possible to transmit the virus out-
side the boundaries of the community if others outside that community come into contact 
with those humans who are infected. The next phase is when the outbreaks of the virus are 
increasing dramatically in many communities in a short period of time. A stage before the 
pandemic is when the transmission of the virus from human to human has been recorded in 
at least two countries. Finally, the pandemic phase means a global pandemic is underway. 
Illness is widespread and governments and worldwide organizations are actively working to 
curtail the spread of the disease, and to help the population deal with it, by using preventive 
measures [49].
Due to the nature of pandemics, we will never be fully protected despite any development in 
antivirals and viral medicine [50]. The following categories are the most ominous: Viral hem-
orrhagic fevers, including Ebola and Marburg Virus, have the potential to turn into pandem-
ics. Influenza—the recent discovery of the H5N1 (Avian Flu) is an example of this. The strain 
was spotted in Vietnam in 2004; the ability of the virus to potentially combine with human 
flu viruses is a concern to scientists. Ebola—the largest Ebola epidemic the world has ever 
seen is still ongoing. Huge efforts have been made in order to prevent it from turning into a 
pandemic. Viral diseases occupy a dominant position in pandemics. The majority of deaths 
worldwide caused by viral pandemics, the mortality of diseases that belong to Flaviviridae 
family are shown in Table 1. A major problem is the immediate and prompt response for pro-
tection before a disease evolves into a pandemic. The progress of science in drug discovery is 
rapid, scientists replace the traditional methods of in vivo/in vitro trial error testing and focus 
more on techniques of rational drug design based on the structure which is efficient, fast and 
of lower cost [51].
To date there is neither a drug nor a specific vaccination available against Zika virus, Ebola 
or HIV virus. Thus there is a great need for the development of novel antiviral strategies. 
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Viruses have a relatively simple structure. They contain nucleic acids in a capsid. The mecha-
nism used for their transmission is based on the host cell. In the end, the host cell is destroyed 
after the creation of multiple copies of the virus. An antiviral strategy for Flaviviridae family 
is to identify which proteins/enzymes are involved in viral replication. Important enzymes 
are the viral helicase and viral polymerases, NS3 and NS5, respectively [52]. The knowledge 
that the helicase plays a key role in the translation of Zika virus leads to the establishment 
and the design of homologous helicase models in order to be used for the rational design of 
an anti-Zika pharmacophore [53]. Also it has been shown that IFN, ribavirin, 6-azauridine 
and glycyrrhizin have the ability to inhibit infection of VERO cells induced with IFN to be 
more effective [54]. Moreover, the combination of IFN and ribavirin may be more effective in 
the Flavivirus genus. Researchers have shown that propoxy derivatives are good candidates 
for drugs against HCV [55]. Anti-malaria hydroxychloroquine indicated inhibition of dengue 
virus infection and has been safely used during pregnancy as well as amodiaquine and tetra-
cyclines [56].
Ebola virus disease (EVD) is a non-segmented, negative-sense, single-stranded RNA virus that 
resembles rhabdoviruses and paramyxoviruses in its genome organization and replication 
mechanisms. It is a member of the family Filoviridae, based upon their filamentous structure. 
The genus Ebola virus is divided into five species (Zaire, Sudan, Ivory Coast, Bundibugyo 
and Reston). Among them, the first four cause disease in humans. The disease has a high risk 
of death, killing between 25 and 90% of those infected, with an average of about 50% [57]. 
The disease was first identified in 1976 in two simultaneous outbreaks, one in Nzara and the 
other in Yambuku, a village near the Ebola River from which the disease took its name. The 
old virus differs from today by 3%. Ebola outbreaks frequently make their appearance in sub-
Saharan Africa. So far the greatest epidemic ever recorded was in western Africa (December 
2013–January 2016) with 11,315 confirmed deaths. Symptoms of Ebola typically include fever, 
Virus Case fatality rate (CFR) Diagnosed (per year) Deaths (per year)
Yellow Fever (YFV) 7.5% 200.000 30.000
Dengue Fever (DENV) 40–50% (without treatment)
1–5% (with treatment)
50–528 million 20.000
Japanese encephalitis virus (JEV) 0.3–60% 70.000 20.400
Tick-borne encephalitis virus (TBE) 20–40% far Easter
2–3% E.U, U.S.A
10.000–15.000 1000
Hepatitis C virus (HCV) 9% 3–4 million 350.000
West Nile virus (WNV) 3–15% 3.000 100
Zika virus (ZIK) — 1,5 million 18 (+71*)
*cases of deaths with microcephaly and/or central nervous system (CNS) 
malformation in newborns.
Table 1. Case fatality rate (CFR) of viruses in Flaviviridae family. Microcephaly and other fetal malformations potentially 
associated with Zika virus infection or suggestive of congenital infection, have been reported in seven countries or 
territories. Particularly, from October 2015 until January 2016, 4783 cases of microcephaly have been reported in Brazil. 
On 29 April the first American died of complications related to the Zika virus, health officials of CDC reported.
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severe headache, muscle pain, weakness and sore throat. Late-stage symptoms of Ebola virus 
may include vomiting, diarrhea, redness in the eyes, swelling of the genitals, internal and 
external bleeding. Typically, symptoms appear 8–10 days after exposure to the virus, but the 
incubation period can span from 2 to 21 days. Recovery may begin between 7 and 14 days 
after first symptoms. Death, if it occurs, follows typically 6–16 days from first symptoms and 
is often due to low blood pressure from fluid loss [58].
Ebola virus is transmitted from human to human by close contact with infected patients and 
virus-containing body fluids. Specifically, it spreads through direct contact with blood or 
body fluids (including but not limited to feces, saliva, sweat, urine, vomit and semen) of a 
person who is sick with or has died from Ebola [59]. Ebola can also be spread through needle 
sticks and contact with objects (like needles and syringes) that have been contaminated with 
the virus. According to WHO, you can also contract the virus by handling a sick or dead wild 
animal that has been infected with it. In the countries of West Africa, transmission through 
infected animals has been observed, usually infecting bats or wild animals as prey. The Ebola 
virus is also a sexually transmitted disease, transmitted by semen (oral, vaginal and anal sex) 
[60]. High-risk groups, except the population of sub-Saharan Africa are people surrounded 
by patients either in the family or in the professional environment. Scientists observing the 
virus have not seen any evidence to suggest that the Ebola virus may be mutating to become 
more contagious.
Ebola is difficult to be diagnosed when a person is first infected because the early symptoms, 
such as fever, are also symptoms of other diseases. The main question doctors consider is 
whether the person has been in one of the countries in West Africa within the last 21 days, 
then tests of blood and tissues can diagnose Ebola. Laboratory diagnosis of Ebola is achieved 
in two ways: detection of infectious particles (or particle components) in affected individu-
als and measurement of specific immune responses to Ebola virus [61]. To date, no FDA-
approved vaccine or medication is available against Ebola virus. Albeit, when some basic 
interventions are used early, they can improve the chances of survival. The basic interventions 
used are providing intravenous fluids (IV) and balancing electrolytes (body salts), maintain-
ing oxygen status and blood pressure and treating other infections if they occur, medications 
to treat shock and pain medications.
Since no therapy has been approved, an important issue that occurs is prevention. Preventive 
methods are vital. WHO and other global health organizations have suggested several types 
of protection, some of them are wash your hands with soap and water or an alcohol-based 
hand sanitizer and avoid contact with blood and body fluids, isolate the patient, wear protec-
tive clothing, dispose of needles and syringes safely, use safe burial practices and avoid facili-
ties in West Africa where Ebola patients are being treated.
To date, the largest outbreak of the Ebola virus was in West Africa. In March 2014, Guinea, 
Liberia and Sierra Leone were the countries where the major outbreak of Ebola appeared. 
In early October of the same year, the first transmission of the virus to occur outside Africa 
was reported, later other patients were identified in Europe and America. The numbers show 
the extent of the problem. In the period 2013–2015 in Liberia, Sierra Leone, Guinea, Nigeria, 
Mali, United States, Senegal, Spain, United Kingdom and Italy, there were 11,315 deaths with 
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case fatality rate of up to70–71%. The United National health agency in December 29, 2015 
declared the end of the Ebola virus transmission in Guinea, Liberia and Sierra Leone, where 
the epidemic began killing 13,000 people [62].
Zika virus was originally isolated in 1947 from the blood of a Rhesus monkey for yellow fever 
research conducted in the Zika forest, Uganda, from which the disease took its name. Then 
the virus was recovered again from humans and mosquitoes in the countries of Central Africa 
and Malaysia. The Zika virus belongs to the genus Flavivirus of the Flaviviridae family. It is 
a single-stranded RNA virus, with a shell and the shape of a sphere. Genomic comparisons 
have revealed that it has two major lineages: Asian and African on the basis of their nucleotide 
sequences. Typical symptoms are fever, headache, maculopapular rash that starts on the face 
and spreads to the whole body, redness in the eyes or conjunctivitis. Symptoms are generally 
mild and start about 2 or 7 days after the infection. Furthermore in some cases, lack of fever 
and often fewer symptoms such as muscle pain and arthralgia have been observed.
The Zika virus is a vector-borne disease, transmitted by several Aedes (stegomyia) species of 
mosquitoes, having been isolated in A. albopictus mosquitoes and A. aegypti. Other reported 
modes of transmission are through mother to fetus, through laboratory exposure, blood 
transfusion and through sexual contact. Transmission through transplantation is possible but 
not proven. The Zika virus has been detected in human blood, saliva, semen and urine. It has 
been confirmed that it remains after 62 days of infection in the patient’s semen and urine. A 
possible mode of transmission is considered to be the bite of infected animals with the virus. 
All these transmission modes of Zika virus make it a challenge for science and for the whole 
world.
Since the virus can be detected in human body fluids, various methods have been developed 
for diagnosing it, through saliva or urine samples that have been collected over 3–5 days after 
the onset of symptoms. It is possible to isolate the viral genome and detect the nucleic acid 
by reverse transcriptase-polymerase chain reaction. Serological tests like ELISA or immuno-
fluorescence are also widely used. CDC had developed an ELISA technique to detect specific 
anti-Zika IGM during the epidemic in Yap in 2007 [63].
Currently, no specific treatment or vaccination is available for Zika virus. Treatment of symp-
toms may include rest, fluids, antipyretics (the CDC advice against using aspirin or other non-
steroidal anti-inflammatory medication) and analgesics. In addition, the CDC has advised 
that pregnant women who are diagnosed with Zika virus should be considered for the moni-
toring of fetal growth and anatomy every 3–4 weeks, because of Zika virus correlation with 
infant microcephaly. Prevent Zika virus by avoiding mosquito bites. Mosquitoes that spread 
Zika virus bite mostly during the daytime. Additionally, sexual transmission of Zika virus 
can be prevented by using condoms or not having sex.
The geographical spread of the virus Zika virus beyond Africa and Asia was reported in 2007. 
The first major expansion with 185 cases occurred in 2007 on the Yap Islands of the Federated 
States of Micronesia. Scientists assume that the introduction of the virus in Yap probably came 
from an infected mosquito or human from Southeast Asia. In 2013, the virus broke out again 
near the French Polynesia. In May 2015, the Ministry of Health of Brazil sounded the alarm 
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because 14 states of the country were affected by the virus. Scientists suspect that Zika virus is 
the cause of 2400 cases of microcephaly and 29 infant deaths in Brazil only in 2015. Currently 
confirmed cases are in 31 countries of South America, 5 countries in Oceania/Pacific Islands 
and in Care Verde. Figure 1 represents all counties with active Zika virus this period March 
2016. The number is expected to increase due to the travel movements (holidays, Olympic 
Games, pilgrimage to Mecca). Furthermore, 80% of cases will not be diagnosed because they 
do not have any symptoms. The distribution of A. aegypti and A. albopictus has remarkable 
parallelisms with the spread of Zika virus.
The climate change has a great affect on the transmission of the Zika virus. A. aegypti is a 
known vector of several viruses, including dengue fever, yellow fever and Zika virus. They 
have identified hundreds of cases in Europe, some ended in death. Probably, it comes from 
Africa, having been transferred globally through trade and sailing ships. Now found in 
tropical, subtropical even in temperate parts. It is relatively small, with black and white pat-
terns. A distinctive external feature is the presence of a silver lyre-shaped sign on the chest. 
A. aegypti has four stages during its life: egg, larva, nymph and adult. In the first three stages, 
it lives in the water and in the last in the air. Females are hematophagous. They lay their eggs 
in temperatures between 25 and 29°C in small water-filled containers. In order to survive in 
a region, they must have adequate temperature and water availability. Humidity is vital not 
only for the eggs but also for the adults. They prefer to host mammals ideally humans [64] and 
artificial ponds. A. aegypti populations exist in northern Brazil, Southeast Asia, India, Greece, 
Spain and temperate regions of North America. Another type of mosquito that transmits dis-
eases and belongs to the same family is A. albopictus. It originates from the tropical forests of 
South-East Asia. They have the same appearance with A. aegypti, and the diagnostic feature 
is the presence of a median silver-scale line against a black background on the thorax. Their 
Figure 1. Areas with active Zika virus (colored dark grey, Category 1), areas with evidence of Zika virus (marked with 
small squares , Category 2) and areas with potential of Zika virus transmission (marked with large squares, Category 3). 
Figure was constructed based on WHO report of March 2017 about Zika virus.
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eggs can survive at −10°C, making them more resistant compared to A. aegypti. A. albopictus 
populations expand geographically over the years. The main reason for the enhanced distri-
bution of vectors A. aegypti and A. albopictus is climate change. Climate change has already 
changed the distribution of certain bodies of animals and is expected to influence it even 
further. According to the European Environment Agency, the global average temperature 
has increased by 0.74°C and the water level is increasing by 1.8 mm every year due to the fact 
that the ice in the Arctic melts at 2.7% each decade. Climate change may cause changes to 
the period and intensity of infectious diseases. The rise in temperature allows the survival of 
insects at higher altitudes. Proof of this can be malaria, which has expanded into areas, where 
previously it did not succeed. Dengue fever has also been seen in Puerto Rico, Florida, Gulf 
Coast states and Hawaii, places that had not usually been affected. Rising temperatures in the 
southern coast of the United States of America areas in Florida, Hawaii and the Coast state 
the following potential residence of A. aegypti together with Zika virus. The wind can reduce 
mosquito bites but also extend their flights. The increased rainfall creates small natural ponds, 
excellent conditions for reproduction and survival of mosquitoes. All these events create a 
clear picture that the protection of global health comes from environmental protection.
Another major factor that has an immediate effect on the transmission of the viruses is the 
mass population transfer from less safe areas to unaffected areas where they could find 
breeding ground for the expansion of the viruses [65]. The communities and the interna-
tional organizations should not be negative toward the population transfer from poorer to 
richer countries or from countries in war to countries in peace as long as extra measures are 
being taken like a database for all immigrants that enter another country, On the other hand, 
the technological achievements of the twenty-first century have annihilated the distances 
and many travelers can be easily transferred all over the globe [66]. Thus, new measures 
are necessary for the population control in all the vulnerable continents like Europe and 
Asia. In addition, an online webpage should be created in order to update on a daily basis 
about the new crusts in each continent for every virus from the ones mentioned above. A 
new more detailed profile for any incoming stigma should be created for every crust. The 
study of every specimen for the immediate tracking of dangerous mutations of the virus 
and the immediate report of different symptoms from the ones expected in case of detecting 
a familiar virus. Phylogeography of the viruses is a new revolutionary idea through which 
we can comprehend and compare the nature of the viruses for the better treatment in case 
of random outbreaks [67].
What do Zika virus and Ebola have in common? Although both Ebola and Zika virus have 
been known for decades, in the last period they have been in the forefront of international 
attention not only for their huge spread but also for the serious consequences they induced. 
Ebola is characterized as a deadly and highly contagious virus. On the other hand, Zika virus 
is not fatal but scientists associate it with microcephaly infants and Guillain-Barré syndrome. 
According to the World Health Organization, both Ebola and Zika virus are infectious dis-
eases that began and spread from animals to humans. Ebola is transmitted through infected 
animal and body fluids. Zika virus mainly through mosquito bites, from mother to fetus and 
isolated cases have reported transmission through semen and blood. The Ebola virus can 
only be transmitted when symptoms are present, the virus incubation period is from 2 to 
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21 days. We do not know if Zika virus is transmitted asymptotically, the incubation period of 
Zika virus has not been calculated exactly, but probably a few days to a week. Both viruses 
have mutated. Ebola causes several symptoms such as fever, vomiting and excessive bleeding 
while Zika virus exhibits mild symptoms or none, since 80% of the cases show no symptoms. 
It is worth to mention that there is neither treatment nor vaccine for both Ebola and Zika virus. 
Ebola is characterized by high mortality rates ranging from 50 to 90%. There are similarities in 
how these two epidemics unfold. Both of them were reported much later, many deaths from 
Ebola until declared an emergency for public health, and many microcephaly cases which 
are believed to be associated with Zika virus. Interesting is the similarities that geographical 
areas have which were inflicted by the two viruses. Ebola started and was mainly reported 
in Guinea, Sierra Leone and Liberia. These countries have a shortage of drinking water, resi-
dents have a poor diet, living in unsightly and unsanitary conditions and made use of pesti-
cides and chemicals. Most cases of Zika virus are found in Brazil, Columbia and El Salvador, 
poor countries with large rural areas, residents have a poor diet with a lack of vitamin A. In 
Brazil, the use of pesticides has increased and has forbidden chemicals from other countries. 
Similarities and differences between Ebola and Zika virus are shown in Table 2.
4. Conclusion
What Ebola and Zika virus should teach us is that we cannot assume that pathogenic viruses 
will continue to behave the same way without being mutated. Both viruses have similarities 
with how they spread. However, we should be mindful that there are some differences between 
Zika virus and Ebola based on fatality and modes of transmission. Zika virus like many of its 
cousins (WNV, dengue and chikungunya) will continue to exist and threaten mankind, until 
answers are provided to several open questions: Are there modes of transmission other than 
through the vector? Are mosquito species other than Aedes is involved in the urban cycle? Can 
person-to-person contamination occur through saliva? Can congenital or sexual transmission 
Similarities Differences
Both of them have been known by 
scientists for decades.
Zika virus typically leads to mild febrile cases, with most being 
asymptomatic, Ebola has severe symptoms.
They are an animal origin in other 
words, a zoonoses.
Ebola has high mortality rate Zika virus not.
No treatment or vaccine The incubation period of Ebola 2–21 of Zika virus few days up to a week
They spread in poor countries Zika virus cannot be transmitted through “casual contact”, as ebola
Had a rapid spread The Ebola can only be transmitted when symptoms are present.
They became epidemics in recent years.
Both viruses have mutated.
Table 2. Similarities and differences of viruses Zika virus end Ebola.
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occur? What is the rate of transmission by blood transfusions? Is ZIKV capable of establish-
ing a chronic infection? Is there the generation of a long-lived protective immune response? Is 
there the possibility of re-infection? These questions must be urgently answered to allow the 
effective design of strategies to prevent and/or treat ZIKV transmission and infection and will 
demand a collective and coordinate basic research initiative to address these issues.
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